This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The Brigham and Women's Hospital, Inc., The Broad Institute, Inc., Dana-Farber-Cancer Institute Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 1,428 
4 out of 486 
3 out of 1,268 
Years Active: 2021-2024
Title: Innovations by Joseph Growney in the Field of Proteinopathies
Introduction
Joseph Growney, an innovative inventor based in Cambridge, MA, has made significant contributions to the understanding and treatment of proteinopathies. With a portfolio of four patents, his work focuses on developing methods for diagnosing and treating diseases associated with toxic protein accumulation, demonstrating a commitment to advancing medical science and patient care.
Latest Patents
One of Growney's latest patents addresses agents for reversing toxic proteinopathies. This groundbreaking disclosure pertains to compositions and methods designed for the diagnosis and treatment or prevention of various proteinopathies, particularly MUC1-associated kidney disease (ADTKD-MUC1 or MKD), retinitis pigmentosa linked to rhodopsin mutations, and autosomal dominant tubulo-interstitial kidney disease due to UMOD mutations (ADTKD-UMOD). Furthermore, this patent identifies TMED9-binding agents capable of treating or preventing proteinopathies of the secretory pathway, showcasing his expertise in therapeutic innovations.
Career Highlights
Throughout his career, Joseph Growney has collaborated with prestigious institutions such as the Broad Institute and Brigham and Women's Hospital. His experience at these organizations has allowed him to thrive in a research environment that prioritizes cutting-edge scientific exploration and collaboration.
Collaborations
In his professional journey, Growney has had the privilege of working alongside esteemed colleagues like Anna Greka and Maria Alimova. These collaborations have not only enriched his research but also fostered an environment of shared knowledge and innovation, enhancing the impact of their work on the medical community.
Conclusion
Joseph Growney is a remarkable inventor whose inventions are paving the way for advancements in the treatment of proteinopathies. His innovative approach and dedication to research reflect a profound commitment to improving patient outcomes and expanding the horizons of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile